← SynDRA
PELANSERIN
SynDRA canonical compound SYN0033383 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | HTR2A |
|---|
| Mechanism of action | serotonin receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- serotonin receptor antagonist
Cross-references
Synonyms
- Pelanserine
- Pelanserina
- Pelanserinum
- 6SNR96E409
- RefChem:170690
- DTXCID6099069
- TR2515
- Pelanserin [INN]
- SR-01000945189
- Pelanserine [French]
- Pelanserinum [Latin]
- Pelanserina [Spanish]
- MLS006011551
- SCHEMBL120877
- UNII-6SNR96E409
- orb1739677
- WPKPLSFHHBBLRY-UHFFFAOYSA-N
- FGA17920
- EBC-13025
- AKOS027327171
- SMR004703317
- T69803
- EN300-2007609
- SR-01000945189-1
- SR-01000945189-2
- BRD-K96436774-001-01-8
- Z379486794
- پلانسرین
- ペランセリン
- Pelanserin hydrochloride (USAN)
- DTXCID40118037
- D05395
- TR-2515
- Pelanserin hcl
- Pelanserin HCl
- Pelanserin Hydrochloride
- UNII-4J8I18ZP0A
- SCHEMBL588973
Look up PELANSERIN in the interactive SynDRA portal →